Susquehanna International Group, LLP Jaguar Health, Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.08 - $809.55 $424 - $4.29 Million	-5,300 Reduced 9.27%	51,900 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.17 - $765.0 $3,383 - $15.2 Million	-19,900 Reduced 25.81%	57,200 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.71 $2,268 - $5,964	-8,400 Reduced 9.82%	77,100 $22,000
Q1 2022 May 16, 2022	BUY	$0.38 - $1.07 $20,862 - $58,743	54,900 Added 179.41%	85,500 $61,000
Q4 2021 Feb 14, 2022	SELL	$1.03 - $2.48 $134,106 - $322,896	-130,200 Reduced 80.97%	30,600 $32,000
Q3 2021 Nov 15, 2021	BUY	$2.14 - $4.95 $344,112 - $795,960	160,800 New	160,800 $365,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $122M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.